Next-Level Technologies for the Problem of Biofilm
Next Science® pioneers innovative, proprietary technologies to address one of the leading causes of antimicrobial resistance, bacterial biofilms. With proven, experienced management and scientific leadership, Next Science and its partners deliver break-through solutions that see beyond the current limits imposed by powerful bacterial colonies.
A Different Perspective
Traditionally, researchers attempting to eradicate difficult-to-treat bacteria have based their efforts on better understanding the bacteria themselves. These efforts have been largely unsuccessful.
Next Science approaches this problem from a different perspective. By applying the principles of material science to a material science problem, Next Science researchers first noticed that the structure of bacterial biofilms behave in ways very similar to those of rubber: both have cross-linked polymers that swell and break apart when fuels pass through them. The Next Science team then devised methods for dissolving these protective bacterial polymers and thus exposing the bacteria to subsequent attack, creating a revolutionary breakthrough for modern science.
Biofilm: A Complex and Widespread Problem
Biofilm accounts for a significant percentage of hard-to-manage bacterial proliferations worldwide.18 Compounding that challenge is the fact that currently available biofilm solutions are extremely hazardous to humans and the environment, and are not always effective. Most current therapies only address planktonic bacteria; they have limited efficacy and are susceptible to resistance.30,31 Through novel material science and a robust development pipeline, Xbio™ technology addresses the problem of biofilm head-on helping to break down the antimicrobial resistance provided by the protective biofilm polymers and thereby helping minimize antibiotic use.
Quality Systems for Next-level Solutions
Next Science is dedicated to creating high-quality solutions for a global impact. This approach focuses on products that are sustainable, safe, and effective. Next Science takes pride in strict adherence to practices that support environmental and antimicrobial responsibility.
Next Science’s manufacturing facility is compliant with 210/211. The GMP facility is registered by FDA for manufacture of Next Science Products. The Next Science Quality Management System is managed in accordance with 21 CFR 820 and ISO 13485.
Latest Media Releases
27/05/2022 09:17:00
Sydney, Australia, Friday, 27 May 2022: Next Science Limited (ASX:NXS) (Next Science/Company) advises that Managing Director and Chief Executive Officer (CEO), Judith Mitchell, has announced her int…
19/05/2022 11:39:00
Sydney, Australia, Thursday, 19 May 2022: Next Science Limited (ASX:NXS) (Next Science) is pleased to announce that it has signed a multi-year distribution agreement for Australia and New Zealand wi…
Latest News
Company Presentations /
by -
9 months ago
23 Sep 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell provides an update on the company's portfolio of biofilm products to help patients with chronic infec…
Company Presentations /
by -
9 months ago
01 Sep 2021 - Next Science (ASX:NXS) Managing Director Judith Mitchell presents on traction growth of the company's products, delivery on key milestones, financials and second hal…
Interviews /
by Michael Luu -
A year ago
02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment o…
Interviews /
by Melissa Darmawan -
A year ago
27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and…
Market Reports /
by Rachael Jones -
A year ago
23 Nov 2020 - It has been a positive day of trade for the ASX. The local bourse managed to close 0.3% higher. Shares in Lynas Corp (ASX:LYC) hit a seven year high. Shares in Insura…
Market Reports /
by Rachael Jones -
2 years ago
08 Apr 2020 - The ASX dropped at the open and struggled to gain momentum closing 0.9% lower. Shares in Oil Search (ASX:OSH) have declined after they reported raising $1.1 billion t…
Company News /
by Katrina Bullock -
2 years ago
13 Dec 2019 - The US Patent Office has granted Biotech company Next Science (ASX:NXS) a patent for the application of Next Science’s unique Xbio technology in its Acne gels and cre…
Market Reports /
by Clive Tompkins -
3 years ago
18 Apr 2019 - Whitehaven Coal’s (ASX:WHC) Winchester South metallurgical coal project has been declared a ‘Coordinated Project’, of strategic significance, by the Queensland Govern…